Zacks.com on MSN6d
MDT Stock Might Gain From Expanded AiBLE Ecosystem and New Partnership
Medtronic expands AiBLE spine surgery ecosystem with new technologies and a partnership with Siemens Healthineers.
Medtronic’s Buy Rating Justified by Growth in CST Sector and AiBLE’s Market Integration
Analyst Josh Jennings from TD Cowen maintained a Buy rating on Medtronic (MDT – Research Report) and keeping the price target at $95.00.
Nasdaq6d
MDT Stock Might Gain From Expanded AiBLE Ecosystem and New Partnership
At the North American Spine Society’s 39th Annual Meeting in Chicago, Medtronic plc MDT commercially launched several software, hardware and imaging innovations to advance its AiBLE spine ...
Pharmabiz6d
Medtronic expands AiBLE spine surgery ecosystem with new technologies and Siemens Healthineers partnership
Medtronic expands AiBLE spine surgery ecosystem with new technologies and Siemens Healthineers partnership: Galway, Ireland Thursday, September 26, 2024, 13:00 Hrs [IST] Medtronic ...
FierceBiotech6d
Medtronic, Siemens Healthineers team up on spine surgery imaging
Two of the top 10 largest medtech companies will partner together on robotic head and spine procedures, with Medtronic ...
stocknews1d
3 MedTech Stocks to Watch as Innovation in Healthcare Soars
MedTech is a promising market driven by rising disease prevalence, innovative healthcare solutions, and significant growth in ...
Becker's Spine Review2d
Medtronic in Q3: 4 notes
Medtronic leaned into its robotics and navigation strategy during the third quarter of 2024. Here are four things to know: 1. On the heels of a strong start for Medtronic's fiscal year 2025, CEO Geoff ...